What is Colorescience?
Headquartered in Carlsbad, California, Colorescience operates as a premium skincare brand that bridges the gap between medical-grade treatments and daily-use cosmetic products. The company specializes in mineral-based sun protection and skin-enhancing solutions that are highly regarded by dermatologists, plastic surgeons, and medical spas. Its business model is characterized by a sophisticated, diversified omni-channel approach, which integrates professional medical channels with direct-to-consumer sales and high-traffic e-commerce platforms. This strategic positioning allows the brand to maintain high consumer trust while capturing significant market share in the competitive beauty and wellness industry.
How much funding has Colorescience raised?
Colorescience has raised a total of $87.6M across 9 funding rounds:
Series A
$10M
Series B
$15M
Debt
$4M
Other Financing Round
$6.5M
Private Equity
$4.2M
Series C
$15M
Debt
$1M
Debt
$30M
Debt
$1.9M
Series A (2013): $10M with participation from Split Rock Partners and Montreux Equity Partners.
Series B (2014): $15M led by Longwood Fund
Debt (2016): $4M, investors not publicly disclosed
Other Financing Round (2016): $6.5M featuring Bridge Bank
Private Equity (2017): $4.2M, investors not publicly disclosed
Series C (2017): $15M with participation from Greenspring Global Partners, Montreux Equity Partners, Healthcare Ventures, and 1315 Capital
Debt (2020): $1M led by PPP
Debt (2020): $30M supported by K2 HealthVentures
Debt (2021): $1.9M featuring PPP
Key Investors in Colorescience
Split Rock Partners
A venture capital firm that invests in software, Internet services, and healthcare companies, providing flexible capital to support entrepreneurs from early revenue generation through market leadership.
Montreux Equity Partners
A growth-focused investment firm specializing in high-growth, commercial-stage companies that offer category-leading products and technologies.
Longwood Fund
A venture capital firm that creates and invests in science-based companies, partnering with world-class scientific co-founders to bring innovative medical therapies to market.
What's next for Colorescience?
Looking ahead, Colorescience is well-positioned to leverage its recent capital influx to accelerate its product development pipeline and deepen its penetration in the global skincare market. The company's focus on clinically validated, science-backed formulations provides a strong competitive moat against mass-market alternatives. As the demand for medical-grade, protective skincare continues to rise, Colorescience is expected to prioritize operational scaling and the expansion of its digital footprint. By maintaining its focus on professional partnerships and high-efficacy product innovation, the firm is poised to sustain its growth trajectory and reinforce its status as a category leader in the aesthetic medicine space.
See full Colorescience company page
